Top neuroscientists from Feinberg and across Chicago joined U.S. Sen. Mark Kirk to announce plans for a $25 million statewide consortium to advance brain research in Illinois.
A new study, led by scientists at the Rehabilitation Institute of Chicago, helps explain the phenomenon of movement chunking, which has important implications for the treatment and rehabilitation of patients with neurological disorders.
Northwestern Medicine scientists have demonstrated how gene therapy targeted against a set of proteins called HCN channels could lead to new treatments for depression.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
A new study identified a link between gene expression levels and protein aggregation, which can lead to neurodegenerative disorders.
Matthew Genet, a first-year medical student, received a 2016 Carolyn L. Kuckein Student Research Fellowship from the Alpha Omega Alpha medical honor society for his brain cancer research.
Dane Chetkovich, MD, PhD, professor of Neurology and Physiology, has received funding from the National Institute of Mental Health to develop novel antidepressant therapies.
A Northwestern Medicine study has shown how signals from neurons in the motor cortex produce precise and consistent movement over time, findings that could inform the design of brain machine interfaces.
Suboptimal social and educational outcomes among young adults with childhood epilepsy persist even when seizures are under control and the disease is in remission, according to a recent study.
Genetic factors and the environment cause depression via different molecular pathways in rats, according a new Northwestern Medicine study.